SCHEMBL4960654

SCHEMBL4960654

O=S(=O)(CCc1ccc2[nH]c3ncccc3c2c1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
CHRM1 P11229 1/20 0.44
DRD1 P21728 1/20 0.44
SLC6A2 P23975 1/20 0.44
HTR1B P28222 1/20 0.44
OPRM1 P35372 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
TBXAS1 P24557 2/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PARP1 P09874 2/20 0.40
MET P08581 1/20 0.40
CHEK1 O14757 1/20 0.40
AURKA O14965 1/20 0.40
BRD4 O60885 2/20 0.39
RORC P51449 1/20 0.39
ADORA2A P29274 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4958627 0.88 MEN1 (0.42) MEN1KMT2APARP1METCHEK1
SCHEMBL4962614 0.83 CHRM2 (0.40) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL4959121 0.82 BRD4 (0.43) MEN1KMT2APARP1CHEK1AURKA
SCHEMBL4959062 0.78 ALK (0.56) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL4960991 0.77 RIPK1 (0.50) MEN1KMT2APARP1METCHEK1
SCHEMBL14594978 0.75 BRD4 (0.68) BRD4
SCHEMBL684505 0.74 KMT2A (0.51) TBXAS1MEN1KMT2A
SCHEMBL4960713 0.74 CHEK1 (0.49) MEN1KMT2APARP1CHEK1AURKA
SCHEMBL4959184 0.72 BRD4 (0.44) MEN1KMT2APARP1CHEK1AURKA
SCHEMBL14594981 0.71 GAA (0.46) MEN1KMT2APARP1METCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896472-A1 ALPHA-CARBOLINES AS CDK-1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2008-03-12 EP disclosed
WO-2006131552-A1 ALPHA-CARBOLINES AS CDK-1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-12-14 WO disclosed